Lawmakers and patients are working to reduce the cost of enzalutamide.

Published Date: 02 Mar 2023

Members of Congress are scrambling to test whether Bayh-Dole's "walk-in" provisions for patents on federally-funded discoveries could lower the cost of certain drugs in the United States.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

2.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

3.

Pulled Myeloma Drug Improves Survival in Trial

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot